Antisoma Inc.
700 Technology Square
Suite 220
Cambridge
Massachusetts
W4 5YF
United States
Tel: 617-252-6100
Fax: 617-252-6101
Website: http://www.antisoma.com/
161 articles about Antisoma Inc.
-
Antisoma PLC Presents at Piper Jaffray Europe Conference
6/23/2008
-
Antisoma PLC Announces AS1413 (Xanafide) Presentation at European Hematology Association
6/16/2008
-
Antisoma PLC Completes Acquisition of Xanthus Pharmaceuticals, Inc.
6/11/2008
-
Antisoma PLC's Acquisition of Xanthus Pharmaceuticals, Inc. Approved by Shareholders
6/9/2008
-
Positive Data on Antisoma PLC's ASA404 presented at American Society of Clinical Oncology
6/2/2008
-
Antisoma PLC Announces Positive ASA404 Presentations at American Society of Clinical Oncology
5/30/2008
-
Antisoma PLC Receives USD 25 Million Milestone Payment from Novartis Corporation
5/29/2008
-
Antisoma PLC To Acquire Xanthus Pharmaceuticals, Inc. For USD $52.2M
5/16/2008
-
Antisoma PLC Interim Management Statement
4/29/2008
-
American Association for Cancer Research Presentation Illustrates Broad Potential of Antisoma PLC's AS1411 in Blood Cancers
4/16/2008
-
Antisoma PLC Licenses Rights to Develop Betagenon's AMPK Activators as Cancer Treatments
4/14/2008
-
Novartis Corporation Starts Phase III Lung Cancer Trial; Triggers $25M Milestone Payment to Antisoma PLC
4/11/2008
-
Antisoma PLC Release: Data on AS1411 Action in Breast Cancer Cells Published in Cancer Research
4/8/2008
-
Antisoma PLC to Present at Cowen and Company 28th Annual Healthcare Conference
3/17/2008
-
Antisoma PLC Starts Phase I Clinical Trial of AS1409 in Renal Cancer and Melanoma
2/21/2008
-
Antisoma PLC Reports Half-year Results
2/21/2008
-
Antisoma PLC to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/8/2008
-
Argenta Discovery Inc. Announces Collaboration with Antisoma PLC
1/9/2008
-
Antisoma PLC to Present at JPMorgan Conference
1/2/2008
-
Antisoma PLC Opens US Headquarters in Princeton, New Jersey
12/20/2007